Unicycive Therapeutics In... (UNCY)

0.54

-0.02 (-4.34%)

At close: Feb 28, 2025, 3:59 PM

0.55

2.67%

After-hours: Feb 28, 2025, 04:00 PM EST

Unicycive Therapeutics Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18
Net Income	-30.54M	-18.06M	-10.02M	-2.26M	-2.17M	-1.12M
Depreciation & Amortization	284K	161K	13K	n/a	n/a	n/a
Stock-Based Compensation	1.77M	1.05M	966K	232K	24K	n/a
Other Working Capital	-1.37M	-89K	-1.35M	-98K	-3K	-25K
Other Non-Cash Items	10.3M	21K	3.25M	739K	660K	308K
Deferred Income Tax	n/a	n/a	127K	n/a	n/a	n/a
Change in Working Capital	-93K	1.18M	-105K	-166K	305K	6K
Operating Cash Flow	-18.28M	-15.65M	-5.77M	-1.46M	-1.18M	-775K
Capital Expenditures	-12K	-2K	-29K	n/a	n/a	n/a
Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-12K	-2K	-29K	n/a	n/a	n/a
Debt Repayment	n/a	n/a	n/a	1.42M	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	27.54M	-482K	22.38M	-117K	1.17M	800K
Financial Cash Flow	27.54M	-471K	22.38M	1.44M	1.17M	800K
Net Cash Flow	9.25M	-16.12M	16.58M	-15K	-10K	25K
Free Cash Flow	-18.3M	-15.65M	-5.8M	-1.46M	-1.18M	-775K